Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:GEN

Genesis Healthcare (GEN) Stock Price, News & Analysis

Genesis Healthcare logo

About Genesis Healthcare Stock (NYSE:GEN)

Key Stats

Today's Range
$27.94
$28.47
50-Day Range
$0.18
$0.60
52-Week Range
$0.40
$1.37
Volume
2.91 million shs
Average Volume
4.10 million shs
Market Capitalization
$17.97 billion
P/E Ratio
31.24
Dividend Yield
1.78%
Price Target
$33.25
Consensus Rating
Moderate Buy

Company Overview

Genesis Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
41st Percentile Overall Score

GEN MarketRank™: 

Genesis Healthcare scored higher than 41% of companies evaluated by MarketBeat, and ranked 213th out of 322 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Genesis Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.

  • Upside Potential

    Genesis Healthcare has a consensus price target of $33.25, representing about 18.2% upside from its current price of $28.12.

  • Amount of Analyst Coverage

    Genesis Healthcare has received no research coverage in the past 90 days.

  • Read more about Genesis Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for Genesis Healthcare are expected to grow by 5.52% in the coming year, from $1.63 to $1.72 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Genesis Healthcare is 31.24, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 281.88.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Genesis Healthcare is 31.24, which means that it is trading at a more expensive P/E ratio than the Business Services sector average P/E ratio of about 26.53.

  • Short Interest

    There is no current short interest data available for GEN.
  • Dividend Yield

    Genesis Healthcare pays a meaningful dividend of 3.05%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Genesis Healthcare does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Genesis Healthcare is 55.56%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Genesis Healthcare will have a dividend payout ratio of 29.07% next year. This indicates that Genesis Healthcare will be able to sustain or increase its dividend.

  • Read more about Genesis Healthcare's dividend.
  • Short Interest

    There is no current short interest data available for GEN.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Genesis Healthcare this week, compared to 2 articles on an average week.
  • Search Interest

    12 people have searched for GEN on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Genesis Healthcare insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.30% of the stock of Genesis Healthcare is held by insiders.

  • Percentage Held by Institutions

    82.08% of the stock of Genesis Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Genesis Healthcare's insider trading history.
Receive GEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genesis Healthcare and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GEN Stock News Headlines

Genesis Health Clubs purchases club No. 79
$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.tc pixel
See More Headlines

GEN Stock Analysis - Frequently Asked Questions

Genesis Healthcare, Inc. (NYSE:GEN) released its earnings results on Thursday, August, 1st. The company reported $0.53 earnings per share for the quarter, meeting the consensus estimate of $0.53. The firm's revenue was up 2.3% on a year-over-year basis.

Genesis Healthcare's board approved a share repurchase plan on Thursday, May 9th 2024, which allows the company to buy back $3,000,000,000 in outstanding shares, according to EventVestor. This means that the company could buy up to 23.1% of its stock through open market purchases. Stock buyback plans are typically a sign that the company's management believes its shares are undervalued.

Based on aggregate information from My MarketBeat watchlists, some other companies that Genesis Healthcare investors own include Invesco QQQ (QQQ), NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
8/01/2024
Today
10/02/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NYSE:GEN
Previous Symbol
NYSE:SKH
CIK
849399
Employees
2,700
Year Founded
N/A

Price Target and Rating

High Price Target
$37.00
Low Price Target
$30.00
Potential Upside/Downside
+18.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.90
Trailing P/E Ratio
31.24
Forward P/E Ratio
17.25
P/E Growth
N/A
Net Income
$836 million
Net Margins
17.83%
Pretax Margin
23.69%
Return on Equity
155.48%
Return on Assets
9.12%

Debt

Debt-to-Equity Ratio
7.50
Current Ratio
0.48
Quick Ratio
0.48

Sales & Book Value

Annual Sales
$2.80 billion
Price / Sales
6.43
Cash Flow
$3.34 per share
Price / Cash Flow
8.42
Book Value
($0.16) per share
Price / Book
-175.75

Miscellaneous

Outstanding Shares
639,130,000
Free Float
618,038,000
Market Cap
$17.97 billion
Optionable
Optionable
Beta
0.84
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NYSE:GEN) was last updated on 10/2/2025 by MarketBeat.com Staff
From Our Partners